DK1094807T3 - E-vitamin og estere deraf til anvendelse i den topiske behandling af slimhindesygdomme - Google Patents

E-vitamin og estere deraf til anvendelse i den topiske behandling af slimhindesygdomme

Info

Publication number
DK1094807T3
DK1094807T3 DK99926687T DK99926687T DK1094807T3 DK 1094807 T3 DK1094807 T3 DK 1094807T3 DK 99926687 T DK99926687 T DK 99926687T DK 99926687 T DK99926687 T DK 99926687T DK 1094807 T3 DK1094807 T3 DK 1094807T3
Authority
DK
Denmark
Prior art keywords
vitamin
vulvitis
esters
topical treatment
dryness
Prior art date
Application number
DK99926687T
Other languages
Danish (da)
English (en)
Inventor
Giorgio Panin
Eleonora Annunziata
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1094807(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Application granted granted Critical
Publication of DK1094807T3 publication Critical patent/DK1094807T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
DK99926687T 1998-07-10 1999-07-05 E-vitamin og estere deraf til anvendelse i den topiske behandling af slimhindesygdomme DK1094807T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (1)

Publication Number Publication Date
DK1094807T3 true DK1094807T3 (da) 2003-08-11

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926687T DK1094807T3 (da) 1998-07-10 1999-07-05 E-vitamin og estere deraf til anvendelse i den topiske behandling af slimhindesygdomme

Country Status (22)

Country Link
EP (1) EP1094807B1 (enExample)
JP (1) JP2002520281A (enExample)
CN (1) CN1135975C (enExample)
AT (1) ATE238051T1 (enExample)
AU (1) AU762860B2 (enExample)
BR (1) BR9911945A (enExample)
CA (1) CA2336990A1 (enExample)
CZ (1) CZ301019B6 (enExample)
DE (1) DE69907193T2 (enExample)
DK (1) DK1094807T3 (enExample)
ES (1) ES2196813T3 (enExample)
HU (1) HU228921B1 (enExample)
IL (1) IL140759A0 (enExample)
IT (1) ITMI981586A1 (enExample)
NO (1) NO20006719L (enExample)
NZ (1) NZ509129A (enExample)
PL (1) PL345500A1 (enExample)
PT (1) PT1094807E (enExample)
RU (2) RU2221561C2 (enExample)
SK (1) SK284464B6 (enExample)
TR (2) TR200100014T2 (enExample)
WO (1) WO2000002554A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
RU2428973C2 (ru) * 2005-03-03 2011-09-20 Вайтал Хэлф Сайнсис Пти Лтд Составы, обладающие липидопонижающими свойствами
JP5731980B2 (ja) * 2008-10-09 2015-06-10 ラムズコア, インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
RU2540481C2 (ru) * 2009-07-27 2015-02-10 Сальваторе Троизи Офтальмологический раствор для защиты внутренних структур глазного яблока от уф-а лучей или для лечения кератоконуса методом трансэпителиального кросс-линкинга
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
LT3209294T (lt) * 2014-10-22 2019-10-25 Bio Lo Ga Srl Farmacinė kompozicija, skirta panaudoti nosies gleivinės trofizmo padidinimui
JP2018507895A (ja) * 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
SU1628281A3 (ru) * 1989-03-30 1994-02-28 Научно-производственная фирма "Флори" Ранозаживляющее средство
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
JP2811036B2 (ja) * 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンe点眼剤
JP3551977B2 (ja) * 1993-04-08 2004-08-11 ライオン株式会社 安定なビタミンa類及びビタミンe類可溶化点眼剤
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
RU2125887C1 (ru) * 1995-08-25 1999-02-10 Владивостокский государственный медицинский университет Способ приготовления липосомального интерферона
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
EP1094807B1 (en) 2003-04-23
ITMI981586A1 (it) 2000-01-10
ATE238051T1 (de) 2003-05-15
NZ509129A (en) 2003-10-31
PL345500A1 (en) 2001-12-17
SK352001A3 (en) 2001-06-11
HUP0102781A2 (hu) 2001-12-28
PT1094807E (pt) 2003-08-29
TR200100014T2 (tr) 2001-06-21
RU2003128023A (ru) 2005-04-10
JP2002520281A (ja) 2002-07-09
SK284464B6 (sk) 2005-04-01
WO2000002554A1 (en) 2000-01-20
AU4385899A (en) 2000-02-01
EP1094807A1 (en) 2001-05-02
CN1308531A (zh) 2001-08-15
BR9911945A (pt) 2001-03-27
IL140759A0 (en) 2002-02-10
DE69907193D1 (de) 2003-05-28
AU762860B2 (en) 2003-07-10
ES2196813T3 (es) 2003-12-16
DE69907193T2 (de) 2004-04-08
CZ200136A3 (cs) 2001-08-15
CN1135975C (zh) 2004-01-28
NO20006719D0 (no) 2000-12-29
CZ301019B6 (cs) 2009-10-14
HU228921B1 (en) 2013-06-28
ITMI981586A0 (it) 1998-07-10
RU2221561C2 (ru) 2004-01-20
NO20006719L (no) 2001-02-16
TR200103710T2 (tr) 2002-06-21
CA2336990A1 (en) 2000-01-20
HUP0102781A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
NO20006719L (no) Vitamin E og estere derav for anvendelse ved topisk behandling av mukopatologier
NO20044699L (no) Vaginalpleiesammensetning
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
DK1385519T3 (da) Tiotropiumsalte til behandling af inflammatoriske sygdomme
IS8255A (is) P38 kínasatálmar staðsettir á 5 hluta heteróhring
MXPA05002033A (es) Una composicion farmaceutica.
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
NO20061214L (no) 2,4-pyrimidindiaminer nyttige i behandling av neoplastiske sykdomme,r inflammatoriske forstyrrelser og immunsystemforstyrrelser
SE0100158D0 (sv) Novel method and composition for local treatment of Meniere´s disease and tinnitus
ES2182915T3 (es) Procedimiento de purificacion del factor viii
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
EA200801698A1 (ru) Лекарственные композиции для применения в вагине
DK1289534T3 (da) Apoptotiske enheder til anvendelse ved behandling af T-cellemedierede og inflammatoriske lidelser
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
IT1318667B1 (it) Medicamento antinfiammatorio.
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
SE0004101D0 (sv) New use
ECSP045210A (es) 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco
SE0102639D0 (sv) Novel compounds
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
AR026241A1 (es) Empleo de carbinoles 2-imidazolil substituidos para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas porestados isquemicos
FR2855400B1 (fr) Dispositif rectal, notamment pour le traitement des hemorrhoides
UA41100A (uk) Вагінальний супозиторій для лікування запальних захворювань піхви та вульви
ITMI991144A1 (it) Acido tricloroacetico per la preparazione di soluzioni e/o composizioni per il trattamento di lesioni erosive e/o ulcerative
RU2003117503A (ru) Способ лечения и профилактики рецидивов генитальной папилломавирусной инфекции